22
Views
9
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Safety and tolerability of the new contraceptive sponge Protectaid®

, &
Pages 91-95 | Published online: 06 Jul 2009

REFERENCES

  • Erny R, Porte H. Efficacite des spermicides. Contracept Fertil Sex 1991;19:289–91
  • Creatsas G. Contraception and sexually transmitted diseases. Eur J Contracept Reprod Health Care 1997;2:259–62
  • Creatsas G. Sexuality: sexual activity and contraception during adolescence. Curr Opin Obstet Gynecol 1993;5:774–83
  • Stein Z. HIV prevention: the need for methods women can use. Am J Public Health 1990;80:460–2
  • Creatsas G, Vekemans M, Horejsi J, et al. Adolescent sexuality in Europe: a multicentric study. Adolesc Pediatr Gynecol 1995;8:59–63
  • Nurithisard S, Roddy R, Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992;39:1371–5
  • Keown K. Historical perspectives on intravaginal contraceptive sponges. Contraception 1997;16:1–5
  • Rosenberg M, Gollub E. Commentary: methods women can use that may prevent sexually transmitted disease, including HIV. Am J Public Health 1992;82:1473–8
  • Trussell J. Contraceptive efficacy. In Hatcher RA, ed. Contraceptive Technology, 17th edn. New York: Contra- ceptive Technology Communications Inc, 1998: 779–884
  • Psychoyos A, Creatsas G, Hassan E, Georgoulias V, Gravanis A. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (ProtectaidÒ) containing sodium cholate. Hum Reprod 1993;8:866–9
  • Cook RL, Rosenberg MJ. Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? A meta-analysis. Sex Transm Dis 1998;25:144–50
  • Hicks D, Martin L. Inactivation of HTLV-III/ LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet 1985;2:1422–3
  • Jick H, Hannan M. Vaginal spermicides and gonorrhea. J Am Med Assoc 1982;248:1619–21
  • Hassan E, Creatsas G, Gravanis A, Georgoulias V, Psychoyos A. Anti-STDs vaginal contraceptive sponges. Ann NY Acad Sci 1997;816:451–6
  • Hassan E, Creatsas G. Contraceptive barrier methods: new developments. In Coll-Capdevilla C, Iglesias L, Creatsas G, eds. Contraception Today. Proceedings of the Fourth Congress of the European Society of Contraception, 12–15 June 1996, Barcelona, Spain. New York: Parthenon Publishing, 1997; 154–60
  • Eckstein P, Jackson M, Millman N, Sobrero A. Com- parison of vaginal tolerance tests of spermicidal prepara- tions in rabbits and monkeys. J Reprod Fertil 1969;20:85–7
  • Chvapil M, Chvapil T, Owen J, Kantor M. Reaction of vaginal tissue of rabbits to inserted sponges made of various materials. J Biomed Mater Res 1979;13:1–13
  • Chvapil M, Chvapil T, Owen J, Keown K. Reaction of vaginal tissue of rabbit and of cheek pouch of hamster to inserted collagen sponges treated either with zinc or copper. Am J Obstet Gynecol 1978;63:130–3
  • Creatsas G, Arefetz N, Eleftheriou N, et al. Cytologic colposcopic and histologic findings in young females using napkins or tampons for menstrual hygiene. Riv Ostet Ginecol 1991;4:98–101
  • Creatsas G, Guerrero E, Guilbert E, et al. A multi- national evaluation of the efficacy, safety and accept- ability of the Protectaid contraceptive sponge. Eur J Contracept Reprod Health Care 2001;6:172–82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.